KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Current Deferred Revenue (2016 - 2025)

Medpace Holdings' Current Deferred Revenue history spans 11 years, with the latest figure at $854.4 million for Q4 2025.

  • For Q4 2025, Current Deferred Revenue rose 20.24% year-over-year to $854.4 million; the TTM value through Dec 2025 reached $854.4 million, up 20.24%, while the annual FY2025 figure was $854.4 million, 20.24% up from the prior year.
  • Current Deferred Revenue reached $854.4 million in Q4 2025 per MEDP's latest filing, up from $834.3 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $854.4 million in Q4 2025 to a low of $277.8 million in Q1 2021.
  • Average Current Deferred Revenue over 5 years is $537.3 million, with a median of $504.7 million recorded in 2023.
  • Peak YoY movement for Current Deferred Revenue: soared 49.97% in 2021, then grew 16.54% in 2025.
  • A 5-year view of Current Deferred Revenue shows it stood at $344.6 million in 2021, then soared by 34.26% to $462.7 million in 2022, then increased by 20.99% to $559.9 million in 2023, then increased by 26.92% to $710.6 million in 2024, then rose by 20.24% to $854.4 million in 2025.
  • Per Business Quant, the three most recent readings for MEDP's Current Deferred Revenue are $854.4 million (Q4 2025), $834.3 million (Q3 2025), and $808.8 million (Q2 2025).